These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 28688841)

  • 1. How MR1 Presents a Pathogen Metabolic Signature to Mucosal-Associated Invariant T (MAIT) Cells.
    McWilliam HEG; Villadangos JA
    Trends Immunol; 2017 Sep; 38(9):679-689. PubMed ID: 28688841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR1 antigen presentation to MAIT cells: new ligands, diverse pathways?
    McWilliam HE; Villadangos JA
    Curr Opin Immunol; 2018 Jun; 52():108-113. PubMed ID: 29754112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
    Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
    Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAIT cells and MR1-antigen recognition.
    Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
    Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1.
    Awad W; Le Nours J; Kjer-Nielsen L; McCluskey J; Rossjohn J
    Immunol Cell Biol; 2018 Jul; 96(6):588-597. PubMed ID: 29393543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
    Corbett AJ; Awad W; Wang H; Chen Z
    Front Immunol; 2020; 11():1961. PubMed ID: 32973800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
    Mondot S; Boudinot P; Lantz O
    Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.
    Meermeier EW; Laugel BF; Sewell AK; Corbett AJ; Rossjohn J; McCluskey J; Harriff MJ; Franks T; Gold MC; Lewinsohn DM
    Nat Commun; 2016 Aug; 7():12506. PubMed ID: 27527800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Diverse Family of MR1-Restricted T Cells.
    Gherardin NA; McCluskey J; Rossjohn J; Godfrey DI
    J Immunol; 2018 Nov; 201(10):2862-2871. PubMed ID: 30397170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigens.
    McWilliam HEG; Mak JYW; Awad W; Zorkau M; Cruz-Gomez S; Lim HJ; Yan Y; Wormald S; Dagley LF; Eckle SBG; Corbett AJ; Liu H; Li S; Reddiex SJJ; Mintern JD; Liu L; McCluskey J; Rossjohn J; Fairlie DP; Villadangos JA
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):24974-24985. PubMed ID: 32958637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.
    Keller AN; Eckle SB; Xu W; Liu L; Hughes VA; Mak JY; Meehan BS; Pediongco T; Birkinshaw RW; Chen Z; Wang H; D'Souza C; Kjer-Nielsen L; Gherardin NA; Godfrey DI; Kostenko L; Corbett AJ; Purcell AW; Fairlie DP; McCluskey J; Rossjohn J
    Nat Immunol; 2017 Apr; 18(4):402-411. PubMed ID: 28166217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intracellular pathway for the presentation of vitamin B-related antigens by the antigen-presenting molecule MR1.
    McWilliam HE; Eckle SB; Theodossis A; Liu L; Chen Z; Wubben JM; Fairlie DP; Strugnell RA; Mintern JD; McCluskey J; Rossjohn J; Villadangos JA
    Nat Immunol; 2016 May; 17(5):531-7. PubMed ID: 27043408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and trafficking of MR1.
    Lamichhane R; Ussher JE
    Immunology; 2017 Jul; 151(3):270-279. PubMed ID: 28419492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells.
    Ussher JE; van Wilgenburg B; Hannaway RF; Ruustal K; Phalora P; Kurioka A; Hansen TH; Willberg CB; Phillips RE; Klenerman P
    Eur J Immunol; 2016 Jul; 46(7):1600-14. PubMed ID: 27105778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAIT Cells in Health and Disease.
    Magalhaes I; Solders M; Kaipe H
    Methods Mol Biol; 2020; 2098():3-21. PubMed ID: 31792812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of MR1 Tetramers Loaded with Microbial Ligands.
    Ladd NA; Froyd CA; Adams EJ
    Methods Mol Biol; 2020; 2098():191-207. PubMed ID: 31792824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR1 presentation of vitamin B-based metabolite ligands.
    McWilliam HE; Birkinshaw RW; Villadangos JA; McCluskey J; Rossjohn J
    Curr Opin Immunol; 2015 Jun; 34():28-34. PubMed ID: 25603223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding and modulating the MR1 metabolite antigen presentation pathway.
    McWilliam HEG; Salio M
    Mol Immunol; 2021 Jan; 129():121-126. PubMed ID: 33293099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells.
    Lepore M; Lewinsohn DA; Lewinsohn DM
    Mol Immunol; 2021 Feb; 130():64-68. PubMed ID: 33360378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR1-restricted T cells: the new dawn of cancer immunotherapy.
    Wang Z; Wang M; Chen J; Zhang L; Zhang L; Yu L
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.